Foresite Capital
Overview
Foresite Capital provides catalytic capital to transformative healthcare companies at all stages.
Investment Focus
- Companies leveraging biology and big data to transform healthcare
- Breakthrough opportunities at the intersection of technology and biotechnology
- Businesses at all stages of their life cycles
Portfolio Companies
Reach Foresite Capital directly
Verified work email, phone and LinkedIn for the full team — one spreadsheet, one payment, yours to keep.
Unlock full contacts →Frequently asked questions about Foresite Capital
What sectors does Foresite Capital invest in?
Foresite Capital invests in Technology, Infrastructure, Software, HealthTech, FoodTech and Transportation, and is based in San Francisco, California, United States. Foresite Capital is listed as a vc in the ConnectSafely investor database.
What stage does Foresite Capital invest at?
Foresite Capital backs companies at Pre-Seed, Seed, Series A and Series B, writing cheques of 5M - 10M.
Which regions does Foresite Capital invest in?
Foresite Capital invests across United States.
Who are the partners at Foresite Capital?
Team members listed for Foresite Capital include Jim Tananbaum (Founder and CEO) and Dennis Ryan (Chief Financial Officer & Managing Director).
What companies has Foresite Capital invested in?
Foresite Capital's portfolio includes Relay Therapeutics, HealthVerity, 10x Genomics, Element Biosciences, Lyell Immunopharma, Inscripta, Gemini Therapeutics and Eikon Therapeutics.
How do I contact Foresite Capital?
Foresite Capital's contact details — including phone and LinkedIn — are listed in the ConnectSafely investor database, along with its website and the LinkedIn profiles of its partners.
Last updated · Source: ConnectSafely investor database
